Immunome, Inc.
665 Stockton Drive, Suite 300
Exton, Pennsylvania 19341
Via EDGAR | May 28, 2021 |
United States Securities and Exchange Commission
Division of Corporate Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Chris Edwards
Re: Immunome, Inc.
Registration Statement on Form S-1
File No. 333-256018
Acceleration Request
Dear Mr. Edwards,
Pursuant to Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, Immunome, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-256018), so that it may become effective at 5:00 p.m. (New York City time) on Tuesday, June 1, 2021, or as soon thereafter as practicable.
Please call Daniel A. Bagliebter, of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, at (212) 692-6856 with any comments or questions regarding the Registration Statement.
Very truly yours, | |
Immunome, Inc. | |
/s/ Purnanand D. Sarma, Ph.D. | |
By: Purnanand D. Sarma, Ph.D. | |
Its: President and Chief Executive Officer |
cc: Sandra G. Stoneman, Chief Legal Officer and General Counsel, Immunome, Inc.
Daniel A. Bagliebter, Esq., Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.